Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

NCT02537574 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

380

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Use Disorder

Interventions

DRUG: NTX/BUP
DRUG: NTX/PBO-B
DRUG: PBO-N/PBO-B

Sponsor

Alkermes, Inc.